MedTech Spectrum

Article Name Medical Finance

Extendicare Reports Strong Q1 2026 Growth, Completes $570Mn CBI Home Health Acquisition

The company posted a strong first-quarter performance, supported by continued momentum in home healthcare, strategic acquisitions and operational efficiencies across its senior care platform

08th May, 2026

VitalHub Reports Strong Q1 2026 Results with 47% Revenue Growth

The healthcare software provider delivered robust top-line growth during the quarter, with revenue rising 47 per cent year-on-year to $31.9 million

08th May, 2026

Imaging and Precision Therapy Drive Siemens Healthineers Q2 Growth

The medtech major delivered overall comparable revenue growth of 3.1 per cent during the quarter

08th May, 2026

Thyrocare Posts Robust Q4FY26 Results on Strong Pathology Growth

Thyrocare reported consolidated revenue of Rs223.95 crore for Q4FY26, reflecting a 20 per cent year-on-year increase

08th May, 2026

Philips Reports Strong Q1 2026 Growth, Maintains Full-Year Outlook

The Dutch health technology major posted group sales of €3.9 billion for the quarter, reflecting a 4 per cent increase in comparable sales

06th May, 2026

How AcuityMD is Redefining MedTech Sales Intelligence

AcuityMD is expanding its AI capabilities to serve not just sales teams, but also marketing and leadership functions, bringing a new level of precision and speed to commercial execution

29th April, 2026

AcuityMD Lands $80 Mn in Funding to Fuel AI Innovation in Medical Device Industry

Nearing $1B valuation and poised for rapid growth, AcuityMD introduces AcuityAI

23rd April, 2026

Tata Elxsi Reports Strong Q4 FY26 Performance; PAT Rises 23% QoQ

For the full financial year FY26, the company reported revenue of Rs3,757.4 crore, underpinned by improved execution, disciplined cost management, and growing customer confidence

22nd April, 2026

CanSino Biologics Returns to Profitability in 2025 as Vaccine Portfolio Drives Growth

The strengthening of routine vaccine sales has contributed to a more balanced revenue mix and enhanced earnings visibility

03rd April, 2026

ADB Backs Major Transformation of Fiji’s Health System

The project will enable real-time digital clinical support for health workers and upgrade health information systems to improve coordinated diagnostics and patient management

13th March, 2026

Middle-Class India and the Health Insurance Dilemma

It demands structural shifts in how premiums are financed and paid

19th February, 2026

Verdane Invests in Clue to Accelerate Future of Women’s Health

The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue

15th January, 2026

Abyrx and Kairuku $450M Deal Forms New MedEdge Surgical Platform

ew capital dedicated to acquiring commercial-stage surgical product companies. The investment will be managed within MedEdge Holdings LLC. This newly formed holding company will use its ownership of Abyrx and Kairuku as the foundation for a broader growth strategy.

26th November, 2025

Scientific Industries Launches AI-Powered Upgrade for VIVID WORKSTATION

Net revenues rose 52.2 per cent to $1,404,000, driven by strong VIVID product demand within the Torbal Division

20th November, 2025

New analysis highlights urgent need to increase adaptation finance for health

Only 0.5% of multilateral climate finance goes to health, despite climate change projected to cause up to 15.6 millions deaths by 2050.

11th November, 2025

Henry Schein Medical Expands SolutionsHub with Colaborate

Through this expansion, laboratories will have direct access to Colaborate's consulting expertise, combined with the reliability and reach of Henry Schein's network and lab capabilities

10th September, 2025

ProVerum Secures $80 Mn Series B Financing to Advance New Treatment for BPH

The ProVee System uses a nitinol stent designed to gently reshape the enlarged BPH prostate and alleviate the associated lower urinary tract symptoms

25th August, 2025

Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and including the Undisturbed Date, and exceeds the highest closing price as quoted on the Stock Exchange since 2022 The proposed privatisation will be effected by way of a scheme of arrangement; the Offeror Concert Parties collectively hold 74.75% shares in the Company; an Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the Proposal The Proposal presents shareholders with certainty over their ability to monetise their interests in Kangji Medical Holdings Limited, following a period of sustained pressure on trading prices and limited liquidity

13th August, 2025